Virtual journey: ATTR amyloidosis


LearnHeartLiving with and treating ATTR amyloidosisVirtual journey: ATTR amyloidosis

Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

Written by Jameson Kowalczyk.
Medically reviewed by nan.
Updated onAugust, 2026
Written by Jameson Kowalczyk.
Medically reviewed by nan.
Updated onAugust, 2026

Featured content

5 answers about ATTR amyloidosis
Article

5 answers about ATTR amyloidosis

How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.

What are the different types of amyloidosis?
Article

What are the different types of amyloidosis?

A guide to three different types of amyloidosis, with a look at causes and underlying conditions.

How does ATTR cardiomyopathy impact your quality of life?
Article

How does ATTR cardiomyopathy impact your quality of life?

Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.

How to seek support when living with ATTR cardiomyopathy
Article

How to seek support when living with ATTR cardiomyopathy

How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.

ATTR-CM: helping a loved one manage multiple medications
Article

ATTR-CM: helping a loved one manage multiple medications

Strategies for caregivers of people with ATTR-CM when a treatment plan involves taking multiple medications.

AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.

ask-mdask-md
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.